ROTFL. The FDA says Phase IV trial are required. Drugs are routinely withdrawn from the market because they cause adverse effects when widely prescribed,
Ann: Media release - First stroke patient with afamelanotide, page-18
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.74 |
Change
0.190(1.31%) |
Mkt cap ! $738.1M | |||
| Open | High | Low | Value | Volume |
| $14.60 | $14.79 | $14.32 | $881.1K | 60.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 87 | $14.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |